Uveal Tract Melanoma

Cohen, Victoria; Papastefanou, Vasilios P.
April 2011
Optometry Today;4/8/2011, Vol. 51 Issue 7, p48
The article reports on uveal tract melanoma, a malignancy of the eye. The different types of melanoma, such as iris, choroidal, and ciliary body, are discussed. Methods to diagnose the melanoma are presented which include slit lamp biomicroscopy, fine needle aspiration biopsy (FNAB), and fluorescein angiography. Treatments for the disease, such as enucleation, plaque radiotherapy, and transpupillary thermotherapy (TTT) are described. Eye removal is no longer necessary with available treatments but the patient is reportedly lost when there is metastases.


Related Articles

  • Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up. H Krema // British Journal of Ophthalmology;Sep2009, Vol. 93 Issue 9, p1172 

    AIMS: To report the treatment outcomes and complication rates of stereotactic radiotherapy in the management of patients with juxtapapillary choroidal melanoma. METHODS: A retrospective review of 64 consecutive patients with juxtapapillary choroidal melanoma, located within 2 mm of the optic...

  • COMS finds little added benefit for radiation before surgery. Samiy, Nasrollah; Straatsma, Bradley R. // Ophthalmology Times; 

    Focuses on the benefits of pre-enucleation radiation therapy for patients with choroidal melanoma. Results of the Collaborative Ocular Melanoma Study; Clinical diagnosis of choroidal melanoma.

  • Choroid Melanoma – A Rare Case Report. SHUKLA, SAMARTH; ACHARYA, SOURYA; DULANI, MANISHA // Journal of Clinical & Diagnostic Research;May2015, Vol. 9 Issue 5, p9 

    Uveal tract encomprise melanomas of the iris, ciliary body and the choroid. The choroid melanomas are more frequent to occur in comparison to iris and ciliary body melanomas. Choroid melanoma though rare, is the most common occurring intraocular malignancy amongst the adults. Incidence of...

  • Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool. Wright, P. K.; Damato, B. E. // Journal of the Royal College of Surgeons of Edinburgh;Aug99, Vol. 44 Issue 4, p260 

    Presents an overview of the treatment of uveal melanoma in patients in Scotland. Treatment by primary enucleation or by conservative methods; Main complications after treatment; Pre-operative management of the patients.

  • High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome. Fili, M.; Lundell, G.; Lundell, M.; Seregard, S. // British Journal of Ophthalmology;Oct2014, Vol. 98 Issue 10, p1349 

    Background Episcleral brachytherapy is the most common eye-preserving option for treating uveal melanoma, with ruthenium-106 widely used in Europe. Case series have reported on ocular outcome, but there are very little data on the impact of dose rate. Therefore, we studied the association of...

  • Choroidal Melanoma is a Life Sentence. Weidmayer, Sara // Review of Optometry;1/15/2012, Vol. 149 Issue 1, p48 

    The article presents a case study of a 65-year-old white male inmate with bugs in the vision of his left eye. It states that the retinal specialist diagnosed that the patient has choroidal melanoma with serous retinal detachment and was referred to an ocuplastics specialist. It mentions that the...

  • CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Scala, Stefania; Ieranò, Caterina; Ottaiano, Alessandro; Franco, Renato; La Mura, Anna; Liguori, Giuseppina; Mascolo, Massimo; Staibano, Stefania; Ascierto, Paolo A.; Botti, Gerardo; De Rosa, Gaetano; Castello, Giuseppe // Cancer Immunology, Immunotherapy;Oct2007, Vol. 56 Issue 10, p1589 

    Although relatively rare, uveal melanoma is the most common ocular tumor of adults. Up to half of uveal melanoma patients die of metastatic disease. CXCR4, a chemokine receptor, is a prognostic factor in cutaneous melanoma involved in angiogenesis and metastasis formation. The aim of this study...

  • Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma. Versluis, Mieke; de Lange, Mark J.; van Pelt, Sake I.; Ruivenkamp, Claudia A. L.; Kroes, Wilma G. M.; Cao, Jinfeng; Jager, Martine J.; Luyten, Gre P. M.; van der Velden, Pieter A. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Uveal melanoma (UM) development and progression is correlated with specific molecular changes. Recurrent mutations in GNAQ and GNA11 initiate UM development while tumour progression is correlated with monosomy of chromosome 3 and gain of chromosome 8q. Hence, molecular analysis of...

  • Irreversible Electroporation of Human Primary Uveal Melanoma in Enucleated Eyes. Mandel, Yossi; Laufer, Shlomi; Belkin, Michael; Rubinsky, Boris; Pe'er, Jacob; Frenkel, Shahar // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Uveal melanoma (UM) is the most common primary intraocular tumor in adults and is characterized by high rates of metastatic disease. Although brachytherapy is the most common globe-sparing treatment option for small- and medium-sized tumors, the treatment is associated with severe adverse...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics